Study: Combo therapy cuts death risk from cryptococcal meningitis

04/4/2013 | HealthDay News

A treatment regimen that combines the antifungal drugs amphotericin B and flucytosine can lower cryptococcal meningitis patients' risk of death by 40% compared to amphotericin B alone, a study in the New England Journal of Medicine showed. Survivors also had lower odds of disability if they were treated with flucytosine, the researchers found.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN